Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alberto Jeronimo"'
Autor:
Sunju Choi, Hittu Matta, Ramakrishnan Gopalakrishnan, Venkatesh Natarajan, Songjie Gong, Alberto Jeronimo, Wei-Ying Kuo, Bryant Bravo, Preet M. Chaudhary
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Cytotoxicity assays are essential for the testing and development of novel immunotherapies for the treatment of cancer. We recently described a novel cytotoxicity assay, termed the Matador assay, which was based on marine luciferases and the
Externí odkaz:
https://doaj.org/article/bc13b55b93244e408c8f65821ee6c580
Autor:
Bryant Bravo, Hittu Matta, Preet M. Chaudhary, Sunju Choi, Venkatesh Natarajan, Wei-Ying Kuo, Ramakrishnan Gopalakrishnan, Alberto Jeronimo, Songjie Gong
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports
Scientific Reports
Cytotoxicity assays are essential for the testing and development of novel immunotherapies for the treatment of cancer. We recently described a novel cytotoxicity assay, termed the Matador assay, which was based on marine luciferases and their engine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4700cba07fd68599494e10f30a400cc
https://doi.org/10.1038/s41598-021-89404-z
https://doi.org/10.1038/s41598-021-89404-z
Autor:
Sunju Choi, Hittu Matta, Venkatesh Natarajan, Anthony Morales, Ramakrishnan Gopalakrishnan, Harishwar Venkatesh, Alberto Jeronimo, Pooja Smruthi Keerthipati, Songjie Gong, Preet M. Chaudhary
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Success of immunotherapeutic approaches using genetically engineered antibodies and T cells modified with chimeric antigen receptors (CARs) depends, among other things, on the selection of antigen binding domains with desirable expression and binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56ccad287435b6b4ef2d04939c193b68
https://doi.org/10.1038/s41598-020-59099-9
https://doi.org/10.1038/s41598-020-59099-9
Autor:
Varun Sikri, Naman Sharma, Kenta Ito, Songjie Gong, Alberto Jeronimo, Venkatesh Natarajan, Sunju Choi, Magdalena Falat, Saurabh Deepak Chitnis, Nell Narasappa, Lalith Namburu, Queenie Qiu, Ankita Batra, Pooja Smruthi Keerthipati, Jason Braun, Hannalei Mae Zamora, Ramakrishnan Gopalakrishnan, Vishan Chaudhary, Hittu Matta, Michael Kahn, Rekha Prakash, Tomas Meza Stieben, Fatima Patel, Ruben Prins, Arta Zenunovic, Preet M. Chaudhary, Supriya Peshin, Allen Membreno, Katelyn Purvis, Dan Wang, Jyotirmayee Lenka, Andrei A. Kochegarov, Jae Han Lee
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Chimeric Antigen Receptor-T (CAR-T) cell immunotherapy has produced dramatic responses in hematologic malignancies. One of the challenges in the field is the lack of a simple assay for the detection of CARs on the surface of immune effector cells. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3832ce2a06f8f6d6e98c54eea010ac90
http://europepmc.org/articles/PMC6374361
http://europepmc.org/articles/PMC6374361